Safety Reporting: What It Is and Why Is It Important
One of the more important aspects of working in pharmaceuticals is ensuring the products are safe for human use. This means the proper...
The Briefing Book
The Briefing Book is, in my opinion, one of the most critical documents in Regulatory Affairs. This is your opportunity to tell your...
Orphan Indications
"The three most important things for companies tackling rare diseases to get right are regulatory affairs, regulatory affairs, and...
EMA Webinar for Type 1 Variations
Copied from the EMA Website: The European Medicines Agency (EMA) is organising a webinar on 15 November 2016 to advise stakeholders on...
